Opus Genetics Cash Flow Statement (2010-2026) | IRD

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-7.14M	-4.23M	-6.31M	-6.59M	-4.93M	-4.53M	33.94M	-5.79M	-4.96M	5.56M	-4.79M	-7.11M	-7.76M	-7.53M	-35.13M	-8.19M	-7.42M	-17.45M	-16.52M	-65.53M
Depreciation and Depletion (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M				0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Share-based Compensation (Quarter)	0.03M	0.03M	0.48M	0.45M	0.45M	0.10M	-1.23M	247.00M	1.42M	0.57M	0.71M	0.24M	0.81M		3.16M	0.91M	0.90M	0.82M	-2.52M	1.46M
Gains from Sales and Divestitures (Quarter)	0.04M	0.04M	0.04M						0.03M		0.03M	0.04M	0.10M	0.14M	0.31M	0.10M	0.28M		0.66M
Gains from Investment Securities (Quarter)	0.26M	0.13M				0.17M		0.29M	0.12M	0.79M	0.03M		0.26M	0.59M		22.23M	22.23M	0.10M
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-4.33M	-3.58M	-5.65M	-6.17M	-3.81M	-4.50M	28.79M	-3.65M	0.99M	-3.00M	4.55M	-5.72M	-7.29M	-5.13M	-7.44M	-8.99M	-10.27M	-6.16M	-9.83M	-12.73M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M				0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Change in Working Capital
Change in Receivables (Quarter)							1.30M	1.54M	-2.70M	10.00M	-9.21M	1.00M	-0.57M	0.50M	1.71M	-0.48M	0.32M	-0.48M	-0.92M	-0.26M
Change in Account Payables (Quarter)	-0.04M	0.06M	0.17M	-0.01M	0.31M	-0.43M	-0.39M	1.15M	0.10M	-0.55M	0.37M	-0.09M	-1.43M	0.20M	1.54M	-0.72M	-0.98M	0.91M	0.80M	1.16M
Change in Accured Expenses (Quarter)	0.35M	0.05M	0.61M	-0.32M	0.00M	-0.19M	0.46M	0.25M	1.50M	-1.51M	-0.12M	1.73M	-0.16M	1.75M	2.35M	0.27M	-1.95M	-0.95M	-0.87M	0.43M
Other Working Capital Changes (Quarter)	41.00	41.00	0.75M	-0.22M	82.00	-0.14M	0.85M	-0.36M	-0.36M	-0.25M	0.61M	0.46M	-0.45M	-0.69M	0.04M	0.86M	0.05M	-0.62M	0.97M	2.14M
Investing Activities
Capital Expenditures (Quarter)
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)			-0.10M												1.21M
Financing Activities
Other financing activities (Quarter)	0.20M	0.10M	0.19M	0.03M	0.05M	0.04M	0.01M			0.20M	0.17M	0.06M	0.03M	0.10M	0.05M	1.41M	0.16M	0.10M	0.10M	0.10M
Cash from Financing Activities (Quarter)	17.96M	1.60M	8.03M	0.88M	1.59M	1.33M	-0.01M			5.38M	3.60M	2.38M	1.54M	0.35M	-0.08M	20.46M	0.91M	4.54M	24.11M	27.59M
Additional items
Change in Cash (Quarter)	13.64M	-1.98M	2.28M	-5.29M	-2.22M	-3.17M	28.78M	-3.65M	0.99M	2.37M	8.15M	-3.34M	-5.75M	-4.78M	-6.31M	11.47M	-9.36M	-1.61M	14.28M	14.87M
Free Cash Flow (Quarter)	-4.33M	-3.58M	-5.65M	-6.17M	-3.81M	-4.50M	28.79M	-3.65M	0.99M	-3.00M	4.55M	-5.72M	-7.29M	-5.13M	-7.44M	-8.99M	-10.27M	-6.16M	-9.83M	-12.73M
Net Cash Flow (Quarter)	13.64M	-1.98M	2.28M	-5.29M	-2.22M	-3.17M	28.78M	-3.65M	0.99M	2.37M	8.15M	-3.34M	-5.75M	-4.78M	-6.31M	11.47M	-9.36M	-1.61M	14.28M	14.87M

Research Tools

Opus Genetics Cash Flow Statement (2010-2026) | IRD

Create an account

Sign In

Reset Password